Analysts have set 12-month price targets for Voyager Therapeutics, revealing an average target of $18.93, a high estimate of ...

Voyager 1 crossed into interstellar space in 2012, followed by Voyager 2 in 2018, making them the only spacecraft to operate ...

Q4 2024 Earnings Call Transcript March 11, 2025 Voyager Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Wells Fargo analyst Yanan Zhu lowered the firm’s price target on Voyager Therapeutics (VYGR) to $10 from $12 and keeps an Overweight rating on ...

In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on Voyager Therapeutics (VYGR – Research Report), with a ...

Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of -68.57% and 68.81%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...

Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $34.5 million in its fourth quarter. On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 59 cents. The ...

Palantir is expanding its AI footprint by partnering with Voyager Technologies to enhance space security. The collaboration ...

S&P 500 E-Mini futures (ESH25) are up +0.41%, andMarch Nasdaq 100 E-Mini futures (NQH25) are up +0.53% this morning, pointing ...

Voyager, a defense technology company, is working with Palantir, an AI software company, to develop enhanced Space Domain ...

No human-made objects have traveled further into the final frontier than Voyager 1 and Voyager 2, but both probes are ...

To help them conserve energy, mission operators at the agency's Jet Propulsion Laboratory (JPL) are shutting off one ...